Navigation Links
New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders

Data to be Presented April 15th at EASL Conference in Barcelona, Spain

VANCOUVER and SAN DIEGO, CA, April 11, 2007 /PRNewswire-FirstCall/ - MIGENIX Inc. , a clinical-stage developer of drugs for infectious diseases, has received new top-line results confirming the previously announced clinical results (November 6, 2006) indicating evidence of clinical benefit, safety and tolerability in a Phase II study using the oral alpha-glucosidase inhibitor, celgosivir (MX-3253), in combination with pegylated interferon and ribavirin.

In addition to confirming the overall conclusions of the original study analysis, retesting resulted in a larger percentage of patients achieving an Early Virologic Response(x) ("EVR") rate with celgosivir plus peginterferon alfa-2b and ribavirin (the "triple combination") as compared to treatment with peginterferon alfa-2b and ribavirin alone (the "control treatment") in patients with chronic hepatitis C virus genotype 1 infections who were characterized as non-responders to prior therapy with optimized pegylated interferon plus ribavirin, achieving:

    -   42% (5/12) EVR with the celgosivir triple combination arm compared to

        10% (1/10) EVR in the control treatment arm. This compares with 33%

        (4/12) EVR (triple combination) vs 10% (1/10) (control treatment) in

        the original study results. (x) EVR = 2 log(10) or greater

        HCV viral load reduction at 12 weeks.


    -   1.63 log(10) (triple combination) mean HCV viral load reduction

        ("VLR") compared to a 0.92 log(10) VLR (control treatment). This

        compares with a 1.2 log(10) VLR (triple combination) vs a 0.4 log(10)

        VLR (control treatment) in the original study results.


    -   a more rapid onset of treatment effect as measured by VLR within the

        first 2 weeks of therapy in the triple combination as compared to the

        control treatment.

Thes
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:9/18/2014)... -- New device to be showcased at ... medical technology company focused on Navigated Brain Stimulation (NBS), announces ... noninvasive presurgical mapping in clinical neurosurgery. The new device will ... of October 2014, one in Europe ... The new NBS 5 system combines MRI-guided Transcranial ...
(Date:9/17/2014)... Sept. 17, 2014 North America Gynecological ... GlobalData,s new report, "North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical ...
(Date:9/17/2014)... , Sept. 17, 2014 BRIC ... Summary GlobalData,s new report, "BRIC ... market data on the BRIC Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
Breaking Medicine Technology:Nexstim Launches Next Generation NBS 5 System 2Nexstim Launches Next Generation NBS 5 System 3Nexstim Launches Next Generation NBS 5 System 4Nexstim Launches Next Generation NBS 5 System 5North America Gynecological Devices Market Outlook to 2020 2North America Gynecological Devices Market Outlook to 2020 3BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3
... May 21 BARC, a global,central laboratory today ... trials currently being performed in South Africa by ... vaccine trials are designed to answer scientific questions,that ... safe and effective,vaccine to prevent HIV infection. The ...
... and long-term survivors validate Jennerex ... breakthrough product approach, SAN ... Francisco, CA and Ottawa, Ontario), and its South,Korean partner Green ... its first-in-class lead product JX-594 were published in,the premier journal ...
Cached Medicine Technology:BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 2BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4
(Date:9/18/2014)... 18, 2014 -- BGI Tech Solutions Co., LTD., ... DLF-Trifolium and the Department of Molecular Biology and ... to develop a series of new high-yielding forage ... , GS is a new form of marker ... QTL-based selection, uses information equally from all available ...
(Date:9/18/2014)... VA (PRWEB) September 18, 2014 ... The organization’s first ever digital edition – rich ... the story of how CRDF Global empowers scientists ... diverse network of government, corporate, foundation and individual ... scientists and innovators in research, training and entrepreneurship. ...
(Date:9/18/2014)... September 18, 2014 Research conducted by ... Allegheny Health Network has documented improved survival in ... removal of the tumors along with stereotactic radiosurgery. , ... ASTRO (American Society for Radiation Oncology) this ... numerous precisely focused radiation beams to treat tumors in ...
(Date:9/18/2014)... South Africa (PRWEB) September 18, 2014 ... to adopt the HABIT™ Program in South ... Indaba Health and Wellness, and distributed in South Africa ... of the HABIT program, which has been tailored to ... IHW HABIT™ focuses on behavior modification and chronic disease ...
(Date:9/18/2014)... This past August, Narconon Louisiana New Life Retreat CEO Cathy ... during the West Feliciana Animal Humane Society fundraiser to support the ... my whole life and have always had animals as part of ... a home. Supporting an animal shelter allows me to help ... The CEO of Narconon Louisiana was there not only to lend ...
Breaking Medicine News(10 mins):Health News:BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods 2Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 3Health News:Narconon New Life Retreat Supports Local Animal Shelter At Recent Fundraiser 2
... its 10th year, the ESMO International Symposium: ... received endorsements from 6 leading professional societies ... Congress as the premier platform for specialists ... clinicians to review the state-of-the-art in gastrointestinal ...
... -- China Sky One,Medical, Inc. (Amex: ... Company"), a China-based,manufacturer, marketer and distributor of ... that its wholly-owned subsidiary,Harbin First Bio-Engineering Pharmaceutical ... development center by the Science and Technology,Institute ...
... Brookdale Senior,Living Inc. (NYSE: BKD ) announced today ... the 2008 Jefferies Healthcare,Conference in New York, New York ... The presentation is being webcast live and can ... website at, http://www.brookdaleliving.com . A replay of the webcast ...
... for ... health plans, WOONSOCKET, R.I., June ... Health Insurance Plans,(AHIP) Institute 2008 to be held June 18-20, 2008 in ... Consumer,Experience" will discuss ways in which health plans can take a proactive,approach ...
... MIAMI and LOS ANGELES, June 19 Cardo ... orthopedic medical devices,and clickNsettle.com, Inc. (OTC Bulletin Board: ... signed a merger agreement pursuant,to which Cardo Medical ... the merger is completed, clickNsettle will be renamed,Cardo ...
... up with Minor League Baseball(TM) to raise awareness of, Benign ... ... U.S., BRIDGEWATER, N.J., June 19 Hall of Fame third,baseman and ... to launch BPH Game Plan Starts with U:,Catch the Whole Game campaign, ...
Cached Medicine News:Health News:10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain 2Health News:China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute 2Health News:China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute 3Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 2Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 3Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 2Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 2Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 4Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 5
Aerosolized Medication Device for Infants. An alternative to aerosol blow-by., ,The PediNeb™ was designed to enhance the delivery of aerosolized medication, while reducing the apprehension enc...
... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
... ULTRA compressor. This high output compressor can ... medication to the patient's lungs. When combined ... LC STAR® Reusable Nebulizer, the particle size ... retention into the lungs. With less medication ...
... Air., ,Allied Healthcares Timeter® PCS 414 portable ... air compressors that you may wonder if its ... 414 features a durable, mar-resistant steel case thats ... weighs only 26.5 pounds. The PCS 414 has ...
Medicine Products: